Literature DB >> 34991379

Influential methods reports for group-randomized trials and related designs.

David M Murray1.   

Abstract

BACKGROUND: This article identifies the most influential methods reports for group-randomized trials and related designs published through 2020. Many interventions are delivered to participants in real or virtual groups or in groups defined by a shared interventionist so that there is an expectation for positive correlation among observations taken on participants in the same group. These interventions are typically evaluated using a group- or cluster-randomized trial, an individually randomized group treatment trial, or a stepped wedge group- or cluster-randomized trial. These trials face methodological issues beyond those encountered in the more familiar individually randomized controlled trial.
METHODS: PubMed was searched to identify candidate methods reports; that search was supplemented by reports known to the author. Candidate reports were reviewed by the author to include only those focused on the designs of interest. Citation counts and the relative citation ratio, a new bibliometric tool developed at the National Institutes of Health, were used to identify influential reports. The relative citation ratio measures influence at the article level by comparing the citation rate of the reference article to the citation rates of the articles cited by other articles that also cite the reference article.
RESULTS: In total, 1043 reports were identified that were published through 2020. However, 55 were deemed to be the most influential based on their relative citation ratio or their citation count using criteria specific to each of the three designs, with 32 group-randomized trial reports, 7 individually randomized group treatment trial reports, and 16 stepped wedge group-randomized trial reports. Many of the influential reports were early publications that drew attention to the issues that distinguish these designs from the more familiar individually randomized controlled trial. Others were textbooks that covered a wide range of issues for these designs. Others were "first reports" on analytic methods appropriate for a specific type of data (e.g. binary data, ordinal data), for features commonly encountered in these studies (e.g. unequal cluster size, attrition), or for important variations in study design (e.g. repeated measures, cohort versus cross-section). Many presented methods for sample size calculations. Others described how these designs could be applied to a new area (e.g. dissemination and implementation research). Among the reports with the highest relative citation ratios were the CONSORT statements for each design.
CONCLUSIONS: Collectively, the influential reports address topics of great interest to investigators who might consider using one of these designs and need guidance on selecting the most appropriate design for their research question and on the best methods for design, analysis, and sample size.

Entities:  

Keywords:  Group-randomized trial; cluster-randomized trial; individually randomized group treatment trial; stepped wedge cluster-randomized trial; stepped wedge group-randomized trial

Mesh:

Year:  2022        PMID: 34991379      PMCID: PMC9256846          DOI: 10.1177/17407745211063423

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.599


  104 in total

1.  Research designs for studies evaluating the effectiveness of change and improvement strategies.

Authors:  M Eccles; J Grimshaw; M Campbell; C Ramsay
Journal:  Qual Saf Health Care       Date:  2003-02

Review 2.  Reporting and methodological quality of sample size calculations in cluster randomized trials could be improved: a review.

Authors:  Clare Rutterford; Monica Taljaard; Stephanie Dixon; Andrew Copas; Sandra Eldridge
Journal:  J Clin Epidemiol       Date:  2014-12-15       Impact factor: 6.437

Review 3.  Best (but oft-forgotten) practices: designing, analyzing, and reporting cluster randomized controlled trials.

Authors:  Andrew W Brown; Peng Li; Michelle M Bohan Brown; Kathryn A Kaiser; Scott W Keith; J Michael Oakes; David B Allison
Journal:  Am J Clin Nutr       Date:  2015-05-27       Impact factor: 7.045

Review 4.  Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.

Authors:  Monica Taljaard; Karla Hemming; Lena Shah; Bruno Giraudeau; Jeremy M Grimshaw; Charles Weijer
Journal:  Clin Trials       Date:  2017-04-08       Impact factor: 2.486

5.  A random-effects ordinal regression model for multilevel analysis.

Authors:  D Hedeker; R D Gibbons
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

6.  Rationale, Methodological Quality, and Reporting of Cluster-Randomized Controlled Trials in Critical Care Medicine: A Systematic Review.

Authors:  David J Cook; William B Rutherford; Damon C Scales; Neill K J Adhikari; Brian H Cuthbertson
Journal:  Crit Care Med       Date:  2021-06-01       Impact factor: 7.598

Review 7.  The methodological quality of cluster randomised controlled trials for managing tropical parasitic disease: a review of trials published from 1998 to 2007.

Authors:  Russell J Bowater; Sally M E Abdelmalik; Richard J Lilford
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-02-20       Impact factor: 2.184

Review 8.  Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014.

Authors:  Emma Beard; James J Lewis; Andrew Copas; Calum Davey; David Osrin; Gianluca Baio; Jennifer A Thompson; Katherine L Fielding; Rumana Z Omar; Sam Ononge; James Hargreaves; Audrey Prost
Journal:  Trials       Date:  2015-08-17       Impact factor: 2.279

9.  Methods for sample size determination in cluster randomized trials.

Authors:  Clare Rutterford; Andrew Copas; Sandra Eldridge
Journal:  Int J Epidemiol       Date:  2015-07-13       Impact factor: 7.196

10.  Introducing the new CONSORT extension for stepped-wedge cluster randomised trials.

Authors:  Karla Hemming; Monica Taljaard; Jeremy Grimshaw
Journal:  Trials       Date:  2019-01-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.